Evidence map›Paper›PMID 25337295›Full record

ReviewInternational journal of clinical and experimental pathology2014

IgG4-related renal disease: clinical and pathological characteristics.

Naoto Kuroda, Tomoya Nao, Hideo Fukuhara, Takashi Karashima, Keiji Inoue, Yoshinori Taniguchi, Mai Takeuchi, Yoh Zen, Yasuharu Sato, Kenji Notohara and 1 more

Open access · greenAbstract readReview
In one paragraph

Review in International journal of clinical and experimental pathology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 25 citations in OpenAlex.

  1. Complete Treatment Response of Isolated Lacrimal IgG4-Related Disease onMolecular imaging and radionuclide therapy · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Naoto KurodaDepartment of Diagnostic Pathology, Kochi Red Cross Hospital Kochi, Japan.
Tomoya NaoDepartment of Urology, Metabolism and Nephrology, Kochi Medical School, Kochi University Kochi, Japan.
Hideo FukuharaDepartment of Urology, Metabolism and Nephrology, Kochi Medical School, Kochi University Kochi, Japan.
Takashi KarashimaDepartment of Urology, Metabolism and Nephrology, Kochi Medical School, Kochi University Kochi, Japan.
Keiji InoueDepartment of Urology, Metabolism and Nephrology, Kochi Medical School, Kochi University Kochi, Japan.
Yoshinori TaniguchiDepartment of Endocrinology, Metabolism and Nephrology, Kochi Medical School, Kochi University Kochi, Japan.
Mai TakeuchiDepartment of Diagnostic Pathology, Kobe University Graduate School of Medicine Kobe, Japan.
Yoh ZenDepartment of Diagnostic Pathology, Kobe University Graduate School of Medicine Kobe, Japan.
Yasuharu SatoDivision of Pathophisiology, Okayama University Graduate School of Health Sciences Okayama, Japan ; Department of Pathology, Okayama Graduate School of Medicine, Density, Pharmaceutical Sciences Okayama, Japan.
Kenji NotoharaDepartment of Anatomic Pathology, Kurashiki Central Hospital Kurashiki, Okayama, Japan.
Tadashi YoshinoDepartment of Pathology, Okayama Graduate School of Medicine, Density, Pharmaceutical Sciences Okayama, Japan.
Kochi Medical School Hospital · JPKobe University · JPOkayama University · JPJapanese Red Cross Kochi Hospital · JPKurashiki Central Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IgG4-related disease is a recently established systemic condition. Tubulointerstitial nephritis is the most common renal manifestation. Glomerular lesions, particularly membranous glomerulonephritis, can develop simultaneously. Some patients present with serological renal dysfunction associated with elevated IgG or IgE levels and hypocomplementemia, while others are incidentally found to have abnormalities in kidneys on imaging. A majority of patients with IgG4-related kidney disease have similar lesions at other anatomical sites, which help us to suspect this condition. Serum IgG4 elevation (>135 mg/dL) is the most, although not entirely, specific marker for the diagnosis. Imaging findings varies from small nodules to bilateral diffuse abnormalities. In addition to the renal parenchyma, the renal pelvis and perirenal adipose tissue can be affected. Histological features include dense lymphoplasmacytic infiltration, storiform or "bird's eye" fibrosis (highlighted by PAM stain), and IgG4-positive plasma cell infiltration (>10 cells/high-power field and IgG4/IgG-positive cell ratio >40%). Immune complex deposition is detectable in the tubular basement membrane by immunofluorescence and/or electron microscopy. Patients usually respond well to corticosteroids, but highly active diseases may require other immunosuppressive therapies. Further investigations will be required to fully understand pathophysiology underlying this emerging condition.

Indexed as

Autoimmune DiseasesBiomarkersBiopsyGlomerulonephritis, MembranousHumansImmunoglobulin GImmunohistochemistryImmunosuppressive AgentsKidneyNephritis, InterstitialPredictive Value of TestsTreatment OutcomeBiomarkersImmunoglobulin GImmunosuppressive AgentsIgG4-related diseasekidneyreview

Identifiers

PMID25337295
PMCPMC4203266
OpenAlexW1409686286

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.